Publications by authors named "Volker Baum"

Claim this Profile
C
Clinical outcomes of high-risk patients with polycythemia vera after suboptimal response to first-line therapy who switched to ruxolitinib versus nonswitchers: results from the PV-Switch study.
Steffen Koschmieder, Clemens Schulte, Eyck von der Heyde, Lambert Busque, Françoise Boyer-Perrard, Volker Baum

Ther Adv Hematol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large cell neuroendocrine lung carcinoma induces peripheral T-cell repertoire alterations with predictive and prognostic significance.
Petros Christopoulos, Marc A Schneider, Farastuk Bozorgmehr, Jonas Kuon, Walburga Engel-Riedel, Volker Baum

Lung Cancer· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor activities of PSMA×CD3 diabodies by redirected T-cell lysis of prostate cancer cells.
Volker Baum, Patrick Bühler, Dorothee Gierschner, Dieter Herchenbach, Gina J Fiala

Immunotherapy· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An antibody fusion protein for cancer immunotherapy mimicking IL-15 trans-presentation at the tumor site.
Vanessa Kermer, Volker Baum, Nora Hornig, Roland E Kontermann, Dafne Müller

Mol Cancer Ther· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective targeting of prostate cancer by lymphocytes redirected by a PSMA × CD3 bispecific single-chain diabody.
Kerstin Fortmüller, Karen Alt, Dorothee Gierschner, Philipp Wolf, Volker Baum

Prostate· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis